October 30, 2007

Rheumatology News
Mayo Clinic Researchers Report Disheartening Data on RA Mortality

Despite earlier diagnoses and a plethora of new drugs, RA patients are living no longer today than they were 40 years ago and are falling ever farther behind the survival curve of the general population...


BioPharm Business News
Novartis' Voltaren (diclofenac) Gel Receives FDA Approval as First Topical NSAID Prescription Treatment for OA Pain of the Knees and Hands

Novartis Pharmaceuticals AG announced that Voltaren Gel (diclofenac sodium topical gel) 1% has received US FDA regulatory approval as the first topical nonsteroidal anti-inflammatory drug (NSAID) prescription treatment for use in treating pain associated with osteoarthritis (OA) in joints amenable to topical treatment...


Rheumatology News
Rituximab May "Reboot" Immune System in Some Lupus Patients

A subgroup of systemic lupus erythematosus (SLE) patients treated with rituximab to deplete B-cells have delayed recovery of memory B-cells in addition to a prolonged response, suggesting that treatment helps ¡°reboot¡± the immune system...


Rheumatology News
Research Shows Why Fibromyalgia Patients Don't Find Relief From Opioids

Fibromyalgia patients have abnormal functioning in a brain receptor involved in response to opioids, which may explain why they may not receive pain relief from narcotics or may require unusually high doses¡­...



The Scientific Basis of Individualized Treatment of Patients With RA: Online Byte-Size CME

To remove your e- mail address from our mailing list, please send a blank email to unsubscribe@fbhc.org. For questions and comments regarding this newsletter please contact info@ciaomed.org